Login to Your Account

Clinic Roundup

Friday, January 27, 2012
• Auxilium Pharmaceuticals Inc., of Malvern, Pa., initiated a Phase Ib trial of Xiaflex (collagenase clostridium histolyticum) for edematous fibrosclerotic panniculopathy, or cellulite. Xiaflex, a collagenase mixture that breaks down collagen, is approved for Dupuytren's contracture and would work similarly in cellulite to release the collagen tethers that cause skin dimpling.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription